ATE247096T1 - Tetrahydropyranderivate und deren verwendung als therapeutische mittel - Google Patents

Tetrahydropyranderivate und deren verwendung als therapeutische mittel

Info

Publication number
ATE247096T1
ATE247096T1 AT00911045T AT00911045T ATE247096T1 AT E247096 T1 ATE247096 T1 AT E247096T1 AT 00911045 T AT00911045 T AT 00911045T AT 00911045 T AT00911045 T AT 00911045T AT E247096 T1 ATE247096 T1 AT E247096T1
Authority
AT
Austria
Prior art keywords
therapeutic agents
tetrahydropyran derivatives
compounds
tetrahydropyran
derivatives
Prior art date
Application number
AT00911045T
Other languages
English (en)
Inventor
Simon Neil Owen
Eileen Mary Seward
Christopher John Swain
Brian John Williams
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9906480.0A external-priority patent/GB9906480D0/en
Priority claimed from GBGB9924616.7A external-priority patent/GB9924616D0/en
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Application granted granted Critical
Publication of ATE247096T1 publication Critical patent/ATE247096T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT00911045T 1999-03-19 2000-03-16 Tetrahydropyranderivate und deren verwendung als therapeutische mittel ATE247096T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9906480.0A GB9906480D0 (en) 1999-03-19 1999-03-19 Therapeutic agents
GBGB9924616.7A GB9924616D0 (en) 1999-10-18 1999-10-18 Therapeutic agents
PCT/GB2000/000974 WO2000056727A1 (en) 1999-03-19 2000-03-16 Tetrahydropyran derivatives and their use as therapeutic agents

Publications (1)

Publication Number Publication Date
ATE247096T1 true ATE247096T1 (de) 2003-08-15

Family

ID=26315315

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00911045T ATE247096T1 (de) 1999-03-19 2000-03-16 Tetrahydropyranderivate und deren verwendung als therapeutische mittel

Country Status (23)

Country Link
US (1) US6458830B1 (de)
EP (1) EP1165540B1 (de)
JP (1) JP2002540107A (de)
KR (1) KR20010113773A (de)
CN (1) CN1344264A (de)
AT (1) ATE247096T1 (de)
AU (2) AU746251B2 (de)
BG (1) BG105859A (de)
BR (1) BR0009127A (de)
CA (1) CA2367985A1 (de)
CO (1) CO5150225A1 (de)
CZ (1) CZ20013377A3 (de)
DE (1) DE60004504T2 (de)
EA (1) EA200100902A1 (de)
EE (1) EE200100491A (de)
ES (1) ES2203434T3 (de)
HU (1) HUP0200441A3 (de)
IL (1) IL144236A0 (de)
NO (1) NO20014529L (de)
PE (1) PE20001556A1 (de)
PL (1) PL350123A1 (de)
SK (1) SK13322001A3 (de)
WO (2) WO2000056727A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10001785A1 (de) * 2000-01-18 2001-07-19 Boehringer Ingelheim Pharma NK¶1¶-Rezeptor-Antagonisten zur Behandlung des Restless Legs Syndroms
GB0017256D0 (en) 2000-07-13 2000-08-30 Merck Sharp & Dohme Therapeutic agents
GB0020721D0 (en) 2000-08-22 2000-10-11 Merck Sharp & Dohme Therapeutic agents
PE20020444A1 (es) 2000-09-22 2002-06-14 Merck & Co Inc Antagonistas de receptores de taquiquinina zwitterionica
CA2433835A1 (en) * 2001-01-17 2002-07-25 Merck Sharp & Dohme Limited Tetrahydropyran derivatives as neurokinin receptor antagonists
GB0121874D0 (en) * 2001-09-10 2001-10-31 Merck Sharp & Dohme Therapeutic agents
GB0217068D0 (en) * 2002-07-23 2002-08-28 Merck Sharp & Dohme Therapeutic agents
EP1562975A2 (de) * 2002-10-25 2005-08-17 Yissum Research Development Company Of The Hebrew University Of Jerusalem Steroide welche gruppen zur nachahmung von superoxidase dismutase sowie stickoxid donorgruppen beinhalten und ihre verwendung in der darstellung von medikamenten
US20060166894A1 (en) * 2002-11-29 2006-07-27 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ace-inhibitors having antioxidant and no-donor activity
AU2004218228A1 (en) 2003-03-07 2004-09-16 Merck Sharp & Dohme Limited Tetrahydropyran compounds as tachykinin antagonists
EP1791847A2 (de) 2004-09-08 2007-06-06 Altana Pharma AG Neue 3-thia-10-aza-phenanthrenderivative
AU2005310229A1 (en) * 2004-11-30 2006-06-08 Mallinckrodt Inc. Crystallization method for benzphetamine
WO2006115188A1 (ja) 2005-04-22 2006-11-02 Daiichi Sankyo Company, Limited ヘテロ環化合物
CN100395242C (zh) * 2006-06-08 2008-06-18 华东理工大学 烷氧基萘和萘醌类吡喃碳糖苷化合物及其制备方法
DE102007010077B4 (de) * 2007-02-28 2010-04-08 RUHR-UNIVERSITäT BOCHUM [1,3]-Dioxane zur Modulation von GABAa-Rezeptoren
WO2013004766A1 (en) 2011-07-04 2013-01-10 Ferrari Giulio Nk-1 receptor antagonists for treating corneal neovascularisation
AU2013312819A1 (en) * 2012-09-04 2015-03-26 Lauren Sciences Llc Bolaamphiphilic compounds, compositions and uses thereof
RU2016149812A (ru) 2014-06-06 2018-07-17 Флексус Байосайенсиз, Инк. Иммунорегулирующие средства
UY36390A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido), sus métodos de síntesis y composiciones farmacéuticas que los contienen
UY36391A (es) 2014-11-05 2016-06-01 Flexus Biosciences Inc Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen
BR112017008809A2 (pt) 2014-11-05 2017-12-19 Flexus Biosciences Inc agentes imunorreguladores
HU231150B1 (hu) 2017-03-13 2021-03-29 Richter Gedeon Nyrt Eljárás racém 3-alkilpiperidin-3-karbonsav-etil-észterek optikai izomerjeinek elválasztására
WO2019156074A1 (ja) * 2018-02-06 2019-08-15 第一三共株式会社 アミノアルキル化合物
US20210015834A1 (en) 2018-02-26 2021-01-21 Ospedale San Raffaele S.R.L. Nk-1 antagonists for use in the treatment of ocular pain
WO2021180885A1 (en) 2020-03-11 2021-09-16 Ospedale San Raffaele S.R.L. Treatment of stem cell deficiency

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9301920D0 (en) * 1993-02-01 1993-03-17 Foundation For Ethnobiology Th Polycetylenes

Also Published As

Publication number Publication date
AU746251B2 (en) 2002-04-18
PE20001556A1 (es) 2001-01-13
SK13322001A3 (sk) 2002-02-05
BR0009127A (pt) 2001-12-26
EA200100902A1 (ru) 2002-02-28
IL144236A0 (en) 2002-05-23
DE60004504D1 (de) 2003-09-18
CA2367985A1 (en) 2000-09-28
HUP0200441A3 (en) 2002-09-30
EP1165540B1 (de) 2003-08-13
US6458830B1 (en) 2002-10-01
NO20014529L (no) 2001-11-13
WO2000056727A1 (en) 2000-09-28
ES2203434T3 (es) 2004-04-16
CN1344264A (zh) 2002-04-10
EE200100491A (et) 2002-12-16
DE60004504T2 (de) 2004-06-24
AU3304200A (en) 2000-10-09
AU3304400A (en) 2000-10-09
BG105859A (bg) 2002-04-30
EP1165540A1 (de) 2002-01-02
KR20010113773A (ko) 2001-12-28
PL350123A1 (en) 2002-11-04
WO2000056728A1 (en) 2000-09-28
NO20014529D0 (no) 2001-09-18
HUP0200441A2 (hu) 2002-07-29
JP2002540107A (ja) 2002-11-26
CO5150225A1 (es) 2002-04-29
CZ20013377A3 (cs) 2002-02-13

Similar Documents

Publication Publication Date Title
ATE247096T1 (de) Tetrahydropyranderivate und deren verwendung als therapeutische mittel
ATE340781T1 (de) Cyclohexylderivate und ihre anwendung als therapeutische mittel
ATE556056T1 (de) Pyridylderivate und deren verwendung als therapeutische mittel
ES2120170T3 (es) Antagonistas azaciclicos gem-disustituidos de taquiquininas.
DK0882021T3 (da) Nye phenanthridiner
DE60335911D1 (de) Isochinolinonderivate und deren verwendung als medikamente
BR0113838A (pt) Derivados de n-fenil-2-pirimidina-amina
ATE547416T1 (de) Pyrazolylbenzothiazolderivate und deren verwendung als therapeutische mittel
UY27368A1 (es) Nuevos compuestos
ATE464287T1 (de) Cyclohexyl-sulphone als gamma-sekretase- inhibitoren
DK1697371T3 (da) Azabicykliske heterocykliske forbindelser som cannabinoidreceptormodulatorer
ATE355288T1 (de) Verbindungen und therapeutische methoden
DE69735482D1 (de) Spiro-azacyclische derivate, deren herstellung und verwendung als tachykinin-antagonisten
ES2135769T3 (es) Derivados de isotiourea como inhibidores de no-sintasa.
BR0108088A (pt) Pirrolidinas 1,3-dissubstituìdas e 1,3,3-trissubstituìdas como ligandos receptores de histamina-3 e suas aplicações terapêuticas
DE60013486D1 (de) Verbindungen
ATE391715T1 (de) Heterozyklische mutilinester und deren verwendung als bakterizide
ES2163730T3 (es) Derivados espirocetales y su uso como agentes terapeuticos.
MXPA06007007A (es) Derivados de prolina usados como ingredientes farmaceuticos activos para el tratamiento de tumores.
DE69512940D1 (de) N-hydroxy-harnstoff-derivate als entzündunghemmende mittel
ATE411311T1 (de) Tetrahydropyranverbindungen als tachykininantagonisten
NO20055142L (no) Diarylmetylidenpiperidinderivater, fremstillinger og anvendelser derav
DE602004010186D1 (de) Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2
DE60200935D1 (de) Diazocinderivate und deren verwendung als tryptase inhibitoren
TR200000916T2 (tr) İkameli piperidin türevleri.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties